• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

传统中医:发现抗肝纤维化候选药物的重要来源。

Traditional Chinese medicine: An important source for discovering candidate agents against hepatic fibrosis.

作者信息

Li Wen-Qing, Liu Wen-Hao, Qian Die, Liu Jia, Zhou Shi-Qiong, Zhang Lei, Peng Wei, Su Li, Zhang Hong

机构信息

School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

出版信息

Front Pharmacol. 2022 Aug 23;13:962525. doi: 10.3389/fphar.2022.962525. eCollection 2022.

DOI:10.3389/fphar.2022.962525
PMID:36081936
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9445813/
Abstract

Hepatic fibrosis (HF) refers to the pathophysiological process of connective tissue dysplasia in the liver caused by various pathogenic factors. Nowadays, HF is becoming a severe threat to the health of human being. However, the drugs available for treating HF are limited. Currently, increasing natural agents derived from traditional Chinese medicines (TCMs) have been found to be beneficial for HF. A systemic literature search was conducted from PubMed, GeenMedical, Sci-Hub, CNKI, Google Scholar and Baidu Scholar, with the keywords of "traditional Chinese medicine," "herbal medicine," "natural agents," "liver diseases," and "hepatic fibrosis." So far, more than 76 natural monomers have been isolated and identified from the TCMs with inhibitory effect on HF, including alkaloids, flavones, quinones, terpenoids, saponins, phenylpropanoids, and polysaccharides, etc. The anti-hepatic fibrosis effects of these compounds include hepatoprotection, inhibition of hepatic stellate cells (HSC) activation, regulation of extracellular matrix (ECM) synthesis & secretion, regulation of autophagy, and antioxidant & anti-inflammation, etc. Natural compounds and extracts from TCMs are promising agents for the prevention and treatment of HF, and this review would be of great significance to development of novel drugs for treating HF.

摘要

肝纤维化(HF)是指由各种致病因素引起的肝脏结缔组织发育异常的病理生理过程。如今,肝纤维化正成为对人类健康的严重威胁。然而,可用于治疗肝纤维化的药物有限。目前,越来越多源自中药的天然药物已被发现对肝纤维化有益。通过PubMed、GeenMedical、Sci-Hub、中国知网、谷歌学术和百度学术进行了系统的文献检索,关键词为“中药”“草药”“天然药物”“肝脏疾病”和“肝纤维化”。到目前为止,已从对肝纤维化有抑制作用的中药中分离并鉴定出76种以上的天然单体,包括生物碱、黄酮类、醌类、萜类、皂苷、苯丙素类和多糖等。这些化合物的抗肝纤维化作用包括肝脏保护、抑制肝星状细胞(HSC)激活、调节细胞外基质(ECM)合成与分泌、调节自噬以及抗氧化和抗炎等。中药中的天然化合物和提取物是预防和治疗肝纤维化的有前景的药物,本综述对开发治疗肝纤维化的新药具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1421/9445813/958866649b89/fphar-13-962525-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1421/9445813/056b1cacb6e2/fphar-13-962525-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1421/9445813/1f4fe330e25b/fphar-13-962525-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1421/9445813/aaba35b3a319/fphar-13-962525-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1421/9445813/958866649b89/fphar-13-962525-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1421/9445813/056b1cacb6e2/fphar-13-962525-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1421/9445813/1f4fe330e25b/fphar-13-962525-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1421/9445813/aaba35b3a319/fphar-13-962525-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1421/9445813/958866649b89/fphar-13-962525-g004.jpg

相似文献

1
Traditional Chinese medicine: An important source for discovering candidate agents against hepatic fibrosis.传统中医:发现抗肝纤维化候选药物的重要来源。
Front Pharmacol. 2022 Aug 23;13:962525. doi: 10.3389/fphar.2022.962525. eCollection 2022.
2
The potential of flavonoids in hepatic fibrosis: A comprehensive review.黄酮类化合物在肝纤维化中的潜力:全面综述。
Phytomedicine. 2024 Oct;133:155932. doi: 10.1016/j.phymed.2024.155932. Epub 2024 Aug 8.
3
Advances in Research on the Effectiveness and Mechanism of Active Ingredients from Traditional Chinese Medicine in Regulating Hepatic Stellate Cells Autophagy Against Hepatic Fibrosis.中药活性成分调控肝星状细胞自噬抗肝纤维化作用与机制研究进展。
Drug Des Devel Ther. 2024 Jul 2;18:2715-2727. doi: 10.2147/DDDT.S467480. eCollection 2024.
4
Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula.中药复方抗肝纤维化治疗的研究进展。
J Ethnopharmacol. 2020 Apr 6;251:112442. doi: 10.1016/j.jep.2019.112442. Epub 2019 Dec 28.
5
Recent discovery of tyrosinase inhibitors in traditional Chinese medicines and screening methods.近年来从传统中药中发现的酪氨酸酶抑制剂及筛选方法。
J Ethnopharmacol. 2023 Mar 1;303:115951. doi: 10.1016/j.jep.2022.115951. Epub 2022 Nov 19.
6
New Perspectives on Chinese Medicine in Treating Hepatic Fibrosis: Lipid Droplets in Hepatic Stellate Cells.从新视角看中药治疗肝纤维化:肝星状细胞中的脂滴。
Am J Chin Med. 2023;51(6):1413-1429. doi: 10.1142/S0192415X23500647. Epub 2023 Jul 10.
7
Research progress on the anti-hepatic fibrosis action and mechanism of natural products.天然产物抗肝纤维化作用及机制的研究进展。
Int Immunopharmacol. 2019 Oct;75:105765. doi: 10.1016/j.intimp.2019.105765. Epub 2019 Jul 20.
8
[Study on rational daily administration frequency of Fufang Biejia Ruangan tablet based on integrated serum pharmacologic and pharmacokinetic model].基于血清药物化学与药代动力学整合模型的复方鳖甲软肝片合理日给药频次研究
Zhongguo Zhong Yao Za Zhi. 2013 Jul;38(14):2394-8.
9
Activation of Nrf2/HO-1 signaling: An important molecular mechanism of herbal medicine in the treatment of atherosclerosis the protection of vascular endothelial cells from oxidative stress.激活 Nrf2/HO-1 信号通路:中药治疗动脉粥样硬化保护血管内皮细胞免受氧化应激损伤的重要分子机制。
J Adv Res. 2021 Jul 6;34:43-63. doi: 10.1016/j.jare.2021.06.023. eCollection 2021 Dec.
10
Traditional Chinese medicine in regulating macrophage polarization in immune response of inflammatory diseases.中药在炎症性疾病免疫反应中调节巨噬细胞极化的作用
J Ethnopharmacol. 2024 May 10;325:117838. doi: 10.1016/j.jep.2024.117838. Epub 2024 Feb 3.

引用本文的文献

1
The stem bark decoction of Myrianthus arboreus P. Beauv. (Cecropiaceae) shows anti-uterine leiomyoma effects in Wistar rat.乔木桑科植物多蕊桑(Myrianthus arboreus P. Beauv.)的茎皮煎剂对Wistar大鼠显示出抗子宫肌瘤的作用。
Reprod Fertil. 2025 Jul 26;6(3). doi: 10.1530/RAF-25-0037. Print 2025 Jul 1.
2
An integrative pharmacology-based study on the pharmacological activity and mechanism of xiaoji-chenpi formula (XCF) against MAFLD.基于整合药理学的消积-陈皮方(XCF)抗非酒精性脂肪性肝病药理活性及作用机制研究
Front Pharmacol. 2025 Mar 7;16:1521111. doi: 10.3389/fphar.2025.1521111. eCollection 2025.
3
The role of traditional Chinese medicine on fracture surgery, hospitalization, and total mortality risks in diabetic patients with osteoporosis.

本文引用的文献

1
[Action mechanism and active components of Fuzheng Huayu Recipe against liver fibrosis via regulating macrophage with network pharmacology and transcriptomics methods].[基于网络药理学和转录组学方法从调控巨噬细胞探讨扶正化瘀方抗肝纤维化的作用机制及活性成分]
Zhongguo Zhong Yao Za Zhi. 2022 Jun;47(11):3029-3037. doi: 10.19540/j.cnki.cjcmm.20211214.401.
2
Efficacy and safety of AnluoHuaxian pills on chronic hepatitis B with normal or minimally elevated alanine transaminase and early liver fibrosis: A randomized controlled trial.安络化纤丸治疗谷丙转氨酶正常或轻度升高的慢性乙型肝炎及早期肝纤维化的疗效与安全性:一项随机对照试验
J Ethnopharmacol. 2022 Jul 15;293:115210. doi: 10.1016/j.jep.2022.115210. Epub 2022 Apr 7.
3
中药在糖尿病合并骨质疏松症患者骨折手术、住院和全因死亡率风险中的作用。
PLoS One. 2024 May 2;19(5):e0289455. doi: 10.1371/journal.pone.0289455. eCollection 2024.
4
Anti-Fibrotic Efficacy of Apigenin in a Mice Model of Carbon Tetrachloride-Induced Hepatic Fibrosis by Modulation of Oxidative Stress, Inflammation, and Fibrogenesis: A Preclinical Study.芹菜素通过调节氧化应激、炎症和纤维化对四氯化碳诱导的小鼠肝纤维化模型的抗纤维化作用:一项临床前研究。
Biomedicines. 2023 May 2;11(5):1342. doi: 10.3390/biomedicines11051342.
5
Exosomes in liver fibrosis: The role of modulating hepatic stellate cells and immune cells, and prospects for clinical applications.外泌体在肝纤维化中的作用:调节肝星状细胞和免疫细胞的作用及临床应用前景。
Front Immunol. 2023 Mar 20;14:1133297. doi: 10.3389/fimmu.2023.1133297. eCollection 2023.
6
Treatment of type 2 diabetes mellitus using the traditional Chinese medicine Jinlida as an add-on medication: A systematic review and meta-analysis of randomized controlled trials.采用中药金芪降糖片作为附加药物治疗 2 型糖尿病的系统评价和荟萃分析:随机对照试验。
Front Endocrinol (Lausanne). 2022 Oct 17;13:1018450. doi: 10.3389/fendo.2022.1018450. eCollection 2022.
XSSJS inhibits hepatic fibrosis by promoting the miR-29b-3p/VEGFA axis in vitro and in vivo.
XSSJS 通过促进体外和体内的 miR-29b-3p/VEGFA 轴抑制肝纤维化。
Biosci Rep. 2022 Feb 25;42(2). doi: 10.1042/BSR20212241.
4
The regulatory role and mechanism of autophagy in energy metabolism-related hepatic fibrosis.自噬在能量代谢相关肝纤维化中的调控作用及机制
Pharmacol Ther. 2022 Jun;234:108117. doi: 10.1016/j.pharmthera.2022.108117. Epub 2022 Jan 22.
5
Total C-21 Steroidal Glycosides From Ameliorate Hepatic and Renal Fibrosis by Regulating IL-1β/MyD88 Inflammation Signaling.来自[具体来源未提及]的总C-21甾体糖苷通过调节IL-1β/MyD88炎症信号改善肝纤维化和肾纤维化。
Front Pharmacol. 2021 Oct 26;12:775730. doi: 10.3389/fphar.2021.775730. eCollection 2021.
6
Breviscapine alleviates NASH by inhibiting TGF-β-activated kinase 1-dependent signaling.灯盏花素通过抑制 TGF-β 激活激酶 1 依赖性信号通路缓解 NASH。
Hepatology. 2022 Jul;76(1):155-171. doi: 10.1002/hep.32221. Epub 2021 Dec 19.
7
Germacrone Attenuates Hepatic Stellate Cells Activation and Liver Fibrosis via Regulating Multiple Signaling Pathways.吉马酮通过调节多种信号通路减轻肝星状细胞激活和肝纤维化。
Front Pharmacol. 2021 Oct 5;12:745561. doi: 10.3389/fphar.2021.745561. eCollection 2021.
8
The Novel Chinese Medicine JY5 Formula Alleviates Hepatic Fibrosis by Inhibiting the Notch Signaling Pathway.新型中药JY5配方通过抑制Notch信号通路减轻肝纤维化。
Front Pharmacol. 2021 Sep 22;12:671152. doi: 10.3389/fphar.2021.671152. eCollection 2021.
9
Antioxidant properties of red raspberry extract alleviate hepatic fibrosis via inducing apoptosis and transdifferentiation of activated hepatic stellate cells.红树莓提取物的抗氧化特性通过诱导活化的肝星状细胞凋亡和转分化来减轻肝纤维化。
Biomed Pharmacother. 2021 Dec;144:112284. doi: 10.1016/j.biopha.2021.112284. Epub 2021 Oct 6.
10
Yiguanjian decoction inhibits macrophage M1 polarization and attenuates hepatic fibrosis induced by CCl/2-AAF.一贯煎汤抑制巨噬细胞 M1 极化,减轻 CCl/2-AAF 诱导的肝纤维化。
Pharm Biol. 2021 Dec;59(1):1150-1160. doi: 10.1080/13880209.2021.1961820.